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The role of RND‑type efflux pumps 
in multidrug‑resistant mutants 
of Klebsiella pneumoniae
Rui Ting Ni1,5, Motoyasu Onishi1,5, Minako Mizusawa1, Ryoko Kitagawa2, Takanori Kishino1, 
Futoshi Matsubara3, Tomofusa Tsuchiya1,2, Teruo Kuroda1,2,4 & Wakano Ogawa1,2,3*
The emergence of multidrug‑resistant Klebsiella pneumoniae is a worldwide problem. K. pneumoniae 
possesses numerous resistant genes in its genome. We isolated mutants resistant to various 
antimicrobials in vitro and investigated the importance of intrinsic genes in acquired resistance. 
The isolation frequency of the mutants was  10−7–10−9. Of the multidrug‑resistant mutants, hyper‑
multidrug‑resistant mutants (EB256‑1, EB256‑2, Nov1‑8, Nov2‑2, and OX128) were identified, and 
accelerated efflux activity of ethidium from the inside to the outside of the cells was observed in these 
mutants. Therefore, we hypothesized that the multidrug efflux pump, especially RND‑type efflux 
pump, would be related to changes of the phenotype. We cloned all RND‑type multidrug efflux pumps 
from the K. pneumoniae genome and characterized them. KexEF and KexC were powerful multidrug 
efflux pumps, in addition to AcrAB, KexD, OqxAB, and EefABC, which were reported previously. It 
was revealed that the expression of eefA was increased in EB256‑1 and EB256‑2: the expression of 
oqxA was increased in OX128; the expression of kexF was increased in Nov2‑2. It was found that a 
region of 1,485 bp upstream of kexF, was deleted in the genome of Nov2‑2. K. pneumoniae possesses 
more potent RND‑multidrug efflux systems than E. coli. However, we revealed that most of them 
did not contribute to the drug resistance of our strain at basic levels of expression. On the other 
hand, it was also noted that the overexpression of these pumps could lead to multidrug resistance 
based on exposure to antimicrobial chemicals. We conclude that these pumps may have a role to 
maintain the intrinsic resistance of K. pneumoniae when they are overexpressed. The antimicrobial 
chemicals selected many resistant mutants at the same minimum inhibitory concentration (MIC) or a 
concentration slightly higher than the MIC. These results support the importance of using antibiotics 
at appropriate concentrations at clinical sites.
Klebsiella pneumoniae is an important pathogen that causes urinary tract infection, opportunistic infection, 
and nosocomial infection. This bacterium can be isolated from not only the mammalian intestine but also 
 environment1,2. It belongs to the same Enterobacteriaceae as Citrobacter and Enterobacter. Recently, antibiotic 
resistance levels of these bacteria are increasing, and emerging multidrug-resistant bacteria are a serious problem 
at clinical sites.
Multidrug efflux pumps are one of the mechanisms causing elevated resistance against many kinds of anti-
microbial chemicals, such as antibiotics, dyes, antiseptics, and detergents in bacteria. So far,  AcrAB3,4  OqxAB5, 
 EefAB6,  KexD7,  KmrA8,  KdeA9, and  CepA3 have been reported as multidrug efflux pumps in K. pneumoniae. Of 
them, AcrAB, OqxAB, EefAB, and KexD are classified into the RND family, which is often the most important 
group of multidrug efflux pumps to protect against harmful chemicals in Gram-negatives. It was revealed that 
RND-type multidrug efflux pumps function with three components: inner membrane protein, periplasmic pro-
tein, and outer membrane  protein10. Inner membrane protein possesses a multisite binding pocket and is able 
to recognize various chemicals as its  substrate11. This protein forms a trimeric complex, and the status of each 
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component changes into access, binding, and extrusion in order to expel  substrates11–14. The RND-type efflux 
pump is also thought to play a physiological role such as in colonization of the intestinal tract and release of 
pathogenic factors, in addition to its role in intrinsic resistance to antibiotics and  antiseptics6,15,16.,16.
The expression of some RND-type efflux pumps cannot be detected under laboratory culture  conditions7,17. 
The expression of such pumps often increases to drive multidrug-resistant characteristics in the presence 
of  mutations17,18. In K. pneumoniae, there are reports of clinical isolates overexpressing an RND-type efflux 
 pump19–22. Most of them were reports describing overexpression of AcrB, the best-known RND in K. pneumo-
niae, but this bacterium possesses genes encoding other RNDs like OqxAB, EefAB, and KexD. The risk of such 
RNDs has been insufficiently assessed, even though RNDs are putative risk factors that may drive multidrug 
resistance by mutation(s).
Here, we isolated various drug-resistant mutants and selected strains to investigate the relation between the 
occurrence of multidrug-resistant mutants and RNDs. Exposure to antimicrobials produced super multidrug-
resistant strains in one step.
Results
Isolation of mutants. Klebsiella pneumoniae ATCC 10031 shows hypersensitivity to various antibiotics 
and this strain is suitable to detect changes in levels of drug resistance. We utilized this strain to select drug-
resistant mutants. The mutants were isolated in the presence of kanamycin, cefotaxime, oxacillin, or norfloxacin. 
They are a typical antibiotic from each category of aminoglycosides, cephems, β-lactams (not cephems), and 
quinolones, respectively. We also used novobiocin and ethidium to select mutants because we knew they tended 
to cause more mutants based on experience. As a result, 32 mutants were isolated from kanamycin-containing 
plates; 32 mutants were isolated from cefotaxime-containing plates; 34 mutants were isolated from oxacillin-
containing plates; 49 mutants were isolated from norfloxacin-containing plates; 505 mutants were isolated from 
novobiocin-containing plates; 76 mutants were isolated from ethidium Br-containing plates (Table 1). The fre-
quency isolating of mutants was  10−7–10−9, and this was considered to be in the range of the general frequency 
of mutant isolation.
Then, isolated mutants were tested on L-plates containing erythromycin (8 μg/ml), ethidium Br (64 μg/ml), 
tetraphenylphosphonium Cl (TPP Cl) (128 μg/ml), and tetracycline (4 μg/ml) to assess whether they showed the 
multidrug-resistant phenotype. We chose 285 strains from 505 mutants from novobiocin plates and investigated 
whether they showed multidrug resistance. One oxacillin-resistant mutant, 16 novobiocin-resistant mutants, 
and 68 ethidium Br-resistant mutants showed elevated resistance to more than two chemicals. In kanamycin-
resistant mutants, cefotaxime-resistant mutants, and norfloxacin-resistant mutants, only the resistance level for 
the same chemical used for mutant selection was increased (Table 2).
Table 1.  Isolated mutants at different concentrations of antimicrobial agents and the mutation frequencies. 
+++: Cells grew on the whole surface, n.t.: not tested. a The concentration of an antimicrobial agent was 
determined with the MIC value of each antimicrobial agent in K. pneumoniae ATCC10031. b The number of 
mutants and mutation frequency were calculated with colonies countable on plates.
Antimicrobial agent
MIC in ATCC10031 
(μg/ml)
Number of mutants at each 
concentration of antimicrobial  agenta Total number of 
 mutantsb Frequencyb × 1  × 2  × 4  × 8  × 16  × 32
Kanamycin 1 +++ 32 0 n.t. n.t. n.t. 32 7.5 × 10−9
Cefotaxime 0.015 +++ 32 0 n.t. n.t. n.t. 32 3.4 × 10−9
Oxacillin 32 30 3 1 0 0 n.t. 34 4.5 × 10−9
Norfloxacin 0.03 48 0 1 0 0 n.t. 49 4.0 × 10−9
Novobiocin 1 260 180 49 15 1 0 505 5.7 × 10−9
Ethidium Br 32 61 10 2 3 0 0 76 1.5 × 10−7
Table 2.  Isolation frequency of multidrug resistance in mutants. *The rate of multidrug-resistant mutants in 
investigated strains.
Antimicrobial agent Investigated mutants on agar plate Multidrug-resistant mutants (%)* Number of strains measured MIC
Mutants that showed marked 
multidrug resistance
Kanamycin 32 0 (0%) 0 0
Cefotaxime 32 0 (0%) 0 0
Oxacillin 34 1 (2.9%) 1 1
Norfloxacin 49 0 (0%) 0 0
Novobiocin 285 16 (5.6%) 8 2
Ethidium Br 76 68 (89.5%) 14 2
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Minimum inhibitory concentrations in isolated mutants. Minimum inhibitory concentrations 
(MICs) of antimicrobial chemicals were measured in a part of the mutants, based on resistance to several chemi-
cals on plates. MICs of eight chemicals were measured in nine strains chosen at random from 68 that were 
isolated from ethidium Br plates (Table S1). All mutants showed increased MIC of TPP Cl. Of those, EB256-1 
and EB256-2 showed high MIC of TPP Cl. The strain EB256-2 was also resistant to norfloxacin (Table S1). We 
randomly chose eight of sixteen strains resistant to novobiocin (Table S2). The MIC of four kinds of chemicals 
were increased more than four times in two mutants (Nov1-8 and Nov2-2) (Table 3, Table S2). The oxacillin-
resistant mutant (OX128) showed elevated MICs of norfloxacin, sodium dodecyl sulfate (SDS), and ethidium 
Br compared with the parental strain, ATCC 10031 (Table 3). The MIC of cloxacillin was also increased in this 
strain (Table 3).
Next, we measured MICs of more kinds of antimicrobial chemicals in the five strains (EB256-1, EB256-2, 
Nov1-8, Nov2-2, and OX128) (Table 3). These five mutants showed higher MICs for acriflavine, ethidium Br, 
rhodamine 6G, and TPP Cl than the parental strain.
Ethidium efflux assay. We empirically knew that drug efflux pumps play an important role in resistance 
to macrolides and dyes such as ethidium, rhodamine, and acriflavine. Then, we measured the efflux activity of 
ethidium in isolated mutants (EB256-1, EB256-2, Nov1-8, Nov2-2, and OX128) (Fig. 1). All of these mutants 
extruded ethidium stronger than their parental strain, ATCC 10031. This suggests that multidrug efflux pumps 
contribute to the increased drug resistance in these strains.
Prediction of RND‑type multidrug efflux pump in Klebsiella pneumoniae genome. RND-type 
multidrug efflux pumps are generally the most important for intrinsic resistance to various harmful chemicals 
in Gram negatives. Such efflux pumps, showing extremely wide substrate specificity, have been mostly classified 
into the RND-type in Gram-negative bacteria to  date4,23,24. For the reasons noted above, we hypothesized that 
RND-type pumps lead to the multidrug-resistant phenotype in isolated mutants.
We predicted RND-type multidrug efflux pumps based on information on the genome of K. pneumoniae 
MGH78578, whose whole sequence has been identified (ACCESSION NC_009648).
Amino acid sequences of AcrB, AcrD, AcrF, MdtB, MdtC, YhiV, and CusB from E. coli were referred in order 
to predict RNDs. Predicted proteins that showed more than 40% identity were chosen. Then, it was confirmed 
whether the length of the amino acid residues in the predicted proteins was around 1,000 and the similarity to 
the reference protein was overall and not partial. Twelve genes for RND-type multidrug efflux pumps were iden-
tified in K. pneumoniae (KPN_RS15920 (oqxB), KPN_RS19875, KPN_RS25540 (cusB), KPN_RS11120 (kexD), 
KPN_RS21805 (eefB), KPN_RS11560, KPN_RS02355 (acrB), KPN_RS04245, KPN_RS13595, KPN_RS13600, 
KPN_RS15040, KPN_RS03035) (Table S3)25. Of those, KPN_RS15920 (oqxB)26, KPN_RS25540 (cusB)27, KPN_
RS11120 (kexD)7, KPN_RS21805 (eefB)6, and KPN_RS02355 (acrB)4 were previously reported.
The RND-type multidrug efflux pump functions with three components, and each component localizes 
in the inner membrane, periplasmic space, and outer  membrane10. Genes of the components of the inner 
membrane proteins and periplasmic proteins are often encoded in an operon. KPN_RS19875, KPN_RS11560, 
Table 3.  Minimum inhibitory concentration of antimicrobial agents in isolated mutants. CTAB 
cetyltrimethylammonium bromide
Antimicrobial agent
Minimum inhibitory concentration (μg/ml)
ATCC10031 EB256-1 EB256-2 Nov1-8 Nov2-2 OX128
Erythromycin 8 16 16 4 256 4
Oleandomycin 16 64 64 64  > 1,024 16
Rokitamycin 8 16 16 16 64 8
Gentamicin 0.25 0.25 0.25 0.25 0.5 0.5
Kanamycin 1 1 1 1 1 1
Novobiocin 1 4 4 32 8 2
Acriflavine 4 16 16 16 32 16
Tetracycline 1 1 1 1 4 1
Cloxacillin 8 16 16 128 64 128
Norfloxacin 0.03 0.03 0.25 0.03 0.06 0.25
Chloramphenicol 1 1 1 1 1 1
Benzalkonium Cl 4 4 4 8 16 16
SDS 256 256 256 512 1,024 512
Ethidium Br 32 256 256 256 512 128
Rhodamine 6G 32 256 256 256 1,024 256
TPPCl 64 512 512 256  > 1,024 128
CTAB 16 16 16 32 32 32
Na Cholate 16,000 16,000 16,000 16,000 16,000 16,000
4Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:10876  | https://doi.org/10.1038/s41598-020-67820-x
www.nature.com/scientificreports/
KPN_RS04245, KPN_RS13595, KPN_RS13600, and KPN_RS03035 possessed a putative gene for the periplas-
mic component upstream, but KPN_RS15040 did not have an adjacent gene for the periplasmic component 
like kexD7. KPN_RS13595 and KPN_RS13600 were considered to be orthologs of mdtB and mdtC from E. coli, 
 respectively28,29. They were suggested to form an operon with KPN_RS13590, probably encoding a periplasmic 
component, and it was considered that the products of KPN_RS13590, KPN_RS13595, and KPN_RS13600 
functioned together as one system like MdtABC. Therefore, we hypothesized that there were 11 RND-type drug 
efflux systems in K. pneumoniae MGH78578, although 12 genes for inner membrane components were in the 
genome of this strain (Table S3).
We named KPN_RS19870-KPN_RS19875 kexEF, KPN_RS11565-KPN_RS11560 kexJK, KPN_RS04250-
KPN_RS04245 kexSR, and KPN_RS15040 kexC, respectively. KPN_RS13590-KPN_RS13595-KPN_RS13600, 
considered to be mdtABC orthologs, were named kexVWX, respectively (Table S3).
Gene cloning of deduced RND‑type multidrug efflux pumps. The characterization of several RND-
type multidrug efflux pumps from K. pneumoniae were previously  reported7, 19,27. However, these reports were of 
studies that investigated different conditions performed by different groups. To compare the drug-resistant pat-
tern in the isolated resistant mutants to the substrate specificity of each RND-type pump, we cloned all deduced 
genes encoding RND-type efflux pumps from K. pneumoniae MGH78578 downstream of the lac promoter. 
Then, E. coli (KAM32 or KAM33) and K. pneumoniae ATCC 10031 were transformed with the plasmids. The 
strains E. coli KAM32 and KAM33, derivatives of TG1, lack acrB and acrAB, respectively. Then, we measured the 
MICs of antibiotics, antiseptics, and antimicrobial chemicals in these transformants (Table 4, Table S4). A plas-
Fl
uo
re
sc
en
ce
 in
te
ns
ity
( a
rbi
tra
ry 
u
n
its
 )
Fl
uo
re
sc
en
ce
 in
te
ns
ity
( a
rbi
tra
ry 
u
n
its
 )
Fl
uo
re
sc
en
ce
 in
te
ns
ity
( a
rbi
tra
ry 
u
n
its
 )
Fl
uo
re
sc
en
ce
 in
te
ns
ity
( a
rbi
tra
ry 
u
n
its
 )
1.3
2.3
(a)
(b)
lactate
0 2 4 86
Time (min)
1.5
2.5
lactate
(a)
(c)
0 2 4 86
Time (min)
1.5
2.5
0 2 4 86
Time (min)
(a)
(d)lactate
1.5
3.0
(a)
(e)
(f)
lactate
0 2 4 86
Time (min)
Figure 1.  Ethidium efflux activity in the multidrug-resistant mutants. A total of 20 mM K-lactate was added to 
the cell suspension at the time indicated by the arrow. (a) ATCC 10031, (b) EB256-1, (c) EB256-2, (d) Nov1-8, 
(e) Nov2-2, and (f) OX128.
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mid carrying kexC or kexD was introduced into KAM32 because they were considered to need the periplasmic 
component, AcrA, from the host for their function.
AcrAB, OqxAB, and EefAB showed increased levels of resistance to various chemicals as expected. It was also 
revealed that KexEF showed highly elevated resistance to a wide variety of chemicals like AcrAB, OqxAB, and 
EefAB (Table 4). KexD also showed an increased level of resistance to macrolides and dyes and this result was 
consistent with our previous  report7. KexC and KexVWX increased the MICs of multiple chemicals, although 
the number of substrates was less than for AcrAB. The MIC of SDS was elevated in KAM33/pKJK28 but not 
in ATCC 10031/pKJK28. The MICs of novobiocin in KAM33 with pKLM28 or pKRS28 were twice that of the 
control, but the difference was slight.
The MICs of the antimicrobials were also measured in K. pneumoniae ATCC 10031 transformed with these 
plasmids (Table S4). When K. pneumoniae was used as the host strain, its substrate specificity pattern was mostly 
similar to that in the E. coli host. However, MICs of more chemicals were increased in KAM32/pKC28 than in 
ATCC 10031/pKC28. The sensitivity to antimicrobials as a host cell or the compatibility of KexC and other RND 
components may be related to this phenomenon.
Prediction of the drug efflux pump promoting multidrug resistance. The elevated resistance pat-
terns of multidrug-resistant mutants were compared with the substrate specificity of each RND system in the 
transformants. The five strongest RND-systems (AcrAB, KexAB, KexD, KexEF, and EefABC) were considered to 
be related to the change of phenotype. However, the substrate specificities of these pumps overlapped and it was 
difficult to narrow the search down to one pump based on the substrate specificity of RNDs.
We previously reported a nonsense mutation in acrB in ATCC  1003130. This nonsense mutation was present 
in all mutant genomes (data not shown). Therefore, it was thought that the increased resistance of mutants was 
caused by powerful pumps other than the AcrAB system.
Then, we investigated the mRNA expression of oqxA, kexC, kexE, eefA, and kexD (Fig. 2). The expression of 
eefA was clearly increased in the mutants EB256-1 and EB256-2. The mutant OX128 showed overexpression of 
oqxA. The first report of oqxAB was from a plasmid in E. coli in  200435. An ortholog of oqxAB was not found in 
the E. coli genome, but was found in the K. pneumoniae  genome36. Several transcriptional regulator genes were 
located in the flanking regions of oqxAB in the K. pneumoniae genome, and it was also reported that both rarA, 
located upstream of oqxAB, and oqxR, downstream of oqxAB, were regulator genes of oqxAB5,37. We determined 
the DNA sequence of oqxAB and its flanking region in ATCC 10031 and OX128. As a result, there was no muta-
tion in rarA or oqxR. However, a single substitution (G → T) was found in the intergenic region between rarA 
and oqxA. The mutation was out of the predicted promoters for rarA or oqxA. Also, this substitution did not 
coincide with any sites reported by Mark et al. in  20125.
We could not detect changes in mRNA expressions of oqxA, kexD, kexE, or eefA in the mutant Nov1-8 or 
Nov2-2. However, the levels of resistance to many chemicals were elevated in Nov2-2, and we considered that 
any of the five RND systems would be definitely involved.
We focused on AcrAB again because of the wide substrate specificity of Nov2-2. We also knew that the 
nonsense mutation in ATCC 10031 was weakly suppressed and a small amount of AcrB was produced in ATCC 
 1003130. Then, we investigated if the suppression was facilitated to elevate the AcrB protein expression.
Table 4.  MIC of various antimicrobial agents in E. coli cells transformed with deduced RND-type efflux pump 
gene from K. pneumoniae. n.t. not tested.
Antimicrobial agent
Minimum inhibitory concentration (μg/ml)
Host: E. coli KAM33 Host: E. coli KAM32
pSTV28 pKAC28M pKAB28 pKEF28 pKGH28 pKJK28 pKLM28 pKRS28 pKTU28 pKVWX28 pSTV28 pKC28 pKD28
vector acrAB oqxAB kexEF eefAB kexJK cusAB kexRS kexTU kexVWX vector kexC kexD
Oxacillin 8 1,024  > 1,024 256 256 8 8 8 8 32 16 512 n.t.
Cloxacillin 4 512 64 64 128 4 4 4 4 128 4 32 4
Norfloxacin 0.03 0.25 0.5 0.03 0.125 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
Erythromycin 4 512 4 64 64 4 4 4 4 4 4 4 128
Kanamycin 1 1 1 1 1 1 1 1 1 1 1 1 1
Tetracycline 0.5 4 0.5 2 4 0.5 0.5 0.5 0.5 0.5 0.5 0.5 2
Novobiocin 1 512 8 64 32 1 2 2 1 8 2 8 8
Acriflavine 8 128 64 16 128 8 8 8 8 16 2 2 8
Benzalkonium Cl 4 32 32 8 16 4 4 4 4 4 4 4 8
Hoechst33342 0.5 8 4 4  > 16 0.5 0.5 0.5 0.5 0.5 0.5 0.5 1
Ethidium Br 4 1,024 128 128 1,024 4 4 4 4 4 4 4 32
Rhodamine 6G 8  > 1,024 512 256 1,024 8 8 8 8 8 8 8 32
SDS 64  > 1,024  > 1,024  > 1,024  > 1,024 512 64 64 64 64 64  > 1,024 256
TPPCl 8 1,024 512 256 1,024 8 8 8 8 8 8 8 256
Cholate 5,000  > 40,000 5,000 20,000 10,000 5,000 10,000 5,000 5,000 20,000 10,000 40,000 10,000
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A strong reaction signal for anti-AcrB antibody was detected in Nov2-2, but this protein was slightly smaller 
than AcrB (Fig. 3a). It was indicated that the protein cross-reacting with anti-AcrB antibody but not AcrB was 
overexpressed in Nov2-2. Of the four inner membrane components (OqxB, KexD, KexF, and EefB), the primary 
structure of KexF and EefB showed marked similarity with AcrB, and we tested whether these proteins cross-
react with anti-AcrB antibody. It was revealed that the antibody reacted with KexF, but not with EefB (Fig. 3a).
Increased mRNA expression of kexF was also detected in Nov2-2, although the expression of kexE was at 
almost the same level as in the parent (Figs. 2, 3b). Therefore, we considered that the overexpression of only KexF 
contributed to the multidrug resistance in Nov2-2.
Then, sequencing revealed that 1,485 bp in the upstream region of kexF was deleted in the genome of Nov2-2 
(Fig. 3c). This deleted region included a part of kexE, a deduced promoter region of kexEF, and a deduced regula-
tor gene (KPN_RS19865). The predicted protein of KPN_RS19865 showed high similarity with EnvR from E. coli 
(identity 92%), and KPN_RS19865 was considered to be an encoding gene of the EnvR  ortholog31.
Discussion
We previously reported that K. pneumoniae ATCC 10031 was highly sensitive to various antibiotics and anti-
microbial chemicals because of a nonsense mutation in acrB30. In this study, we isolated multidrug-resistant 
mutants from ATCC 10031 by exposure to antimicrobial chemicals.
The multidrug-resistant mutant OX128 was isolated in the presence of oxacillin and the overexpression of 
oqxAB was clarified in OX128. There have been numerous reports of clinically isolated mutants resistant to 
β-lactams, and the causes of the resistance were acquisition of a β-lactamase gene or reduction of outer membrane 
proteins. Compared with them, reports that drug efflux pumps caused resistance to β-lactams are much fewer. 
Hence, it was suggested that β-lactams were not good substrates for drug efflux pumps. However, our results 
suggest that efflux pumps also possibly caused increased resistance to β-lactams.
We cloned all genes that were deduced to be RND-type efflux pump genes to compare with previously 
reported ones. In addition to acrAB4,32, oqxAB5, eefAB6, and kexD7, we noted that KexEF conferred resistance 
to a wide variety of antimicrobial chemicals. The substrate specificity of KexEF resembled that of EefAB as far 
as we investigated.
Ten kinds of RND-type multidrug efflux pump genes were cloned in Enterobacter cloacae, and the relation-
ship between these pumps and drug resistance was  investigated16. ECL_01758 reported in this article showed 
97% identity with KexD. Although ECL_01758 elevated the MIC of amikacin and gentamicin, KexD did not 
increase the MIC of kanamycin belonging to the same aminoglycoside group. Besides, acriflavine and ethidium 
were good substrates for KexD, but cloned ECL_01758 did not show markedly elevated levels of resistance to 
these chemicals. They both were very similar proteins regarding their primary structure. It is interesting to note 
that the difference of a few amino acids residues between them may cause such different substrate specificities.
Overexpression of eefA was clearly observed in EB256-1 and EB256-2. Meanwhile, resistance to norfloxacin 
was different between EB256-1 and EB256-2, although both were EefAB-overexpressing mutants. The MIC of 
1 2 3 4 5 6 M
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Figure 2.  mRNA expression of oqxA, kexC, kexE, eefA, kexD, and acrA among the multidrug-resistant mutants. 
Lane 1: ATCC 10031, Lane 2: EB256-1, Lane 3:EB256-2, Lane 4: Nov1-8, Lane 5: Nov2-2, Lane 6: OX128, M: 
size marker. The expression of acrA was used as a control. The length of each product and reaction cycle were: 
oqxA, 179 bp, 27 cycles; kexC, 141 bp, 30 cycles; kexE, 117 bp, 29 cycles; eefA, 81 bp, 28 cycles; kexD, 184 bp, 30 
cycles; acrA, 257 bp, 28 cycles. Quick-Load Purple 100 bp DNA Ladder (New England Biolabs Japan Inc.) was 
used as a size marker.
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Figure 3.  Identification of genes responsible for the increased drug resistance of the mutants. (a) A protein detected with anti-AcrB 
antibody. A protein that cross-reacted with anti-AcrB antibody of E. coli was detected by Western blotting. Membrane protein (20 μg) 
was loaded. Lane 1: Nov2-2, Lane 2: MGH78578, Lane 3: ATCC 10031, Lane 4: SKY2, Lane 5: TG1, Lane 6: KAM33, Lane 7: KAM33/
pKEF28, Lane 8: KAM33/pKGH28. Lanes 1–4 were from K. pneumoniae and Lanes 5–8 were from E. coli. (b) mRNA expression 
of kexEF in Nov2-2. The results of reverse transcriptase reaction (RT-PCR) are shown as + RT, with –RT denoting negative controls 
without reverse transcription. RT-PCR for uncB was performed as an internal control. M: size marker, Lane 1: MGH78578, Lane 2: 
ATCC1003, Lane 3: Nov2-2. The annealing temperature was 50 °C for all samples. Reaction cycles were: 31 cycles for kexE and kexF, 
and 27 cycles for uncB. (c) Determination of the deleted region in the Nov2-2 genome. The length of the deleted region in the Nov2-2 
genome was 1,485 bp, which included a part of fis, a whole envR (KPN_RS19865), the deduced promoter region of kexEF, and part of 
kexE.
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norfloxacin was increased in K. pneumoniae ATCC 10031/pKGHA28 and E. coli KAM33/pKGH28, and this result 
coincided with the pattern of EB256-2. Therefore, EB256-1 may possess an additional mutation that decreases 
quinolones resistance.
Tamae et al. reported genes showing super-sensitivity to quinolones with the Keio  collection33, and Han et al. 
also reported genes that increased lethality by exposure to nalidixic acid when  disrupted34. These studies were 
independently performed. It is interesting that the genes reported by each group did not overlap. This means that 
many genes may be related to quinolone resistance. One mutation of these genes reported by Tamae et al. or Han 
et al. might cause the different phenotype of quinolone resistance between EB256-1 and EB256-2.
The mRNA expression of kexE was observed under the laboratory culture conditions (Fig. 2) and it was also 
detected in Nov2-2, which lacked kexE. This is the reason why the primers to test kexE expression were designed 
in the region downstream of the deleted part. kexEF was deduced to form an operon, but it was clear that the 
expression of only kexF was markedly increased in Nov2-2. Therefore, it was suggested that the transcription 
initiation point of kexF mRNA should be downstream from the primer, kexE Fw, used to detect kexE expression.
In this study, we revealed that K. pneumoniae possessed a potent RND-type multidrug efflux pump, KexEF. 
KexEF increased the resistance to various antimicrobial chemicals in the host cells when the genes were cloned 
under lac promoter (Table 4 and Table S4). However, it was considered that KexEF would not play a significant 
role in antimicrobial resistance in ATCC 10031, at least under the laboratory culture conditions. We give two 
reasons for this: Firstly, antibiotic resistance levels were increased in Nov2-2, in which expression levels of kexF 
were markedly increased. Secondly, levels of resistance to antimicrobials were almost the same in K. pneumoniae 
ATCC 10031, a strain deficient in acrB, and E. coli KAM32, an acrB-disrupted strain. This means that KexEF is 
not a system equivalent to AcrAB in K. pneumoniae, although KexEF is a powerful multidrug efflux system. It is 
considered that the typical expression level of KexEF is too low to be an alternative system to AcrAB.
In Nov2-2, kexE was deleted and only KexF was overexpressed. Then, KexF was considered to co-work with 
AcrA in Nov2-2 because AcrA shows high-level similarity with KexE and is expressed at a higher level than any 
other periplasmic components of RND-type multidrug efflux systems. The deletion of envR caused overexpression 
of KexF in the mutant strain, Nov2-2. This result suggests that the lack of EnvR, a possible repressor of kexEF, 
and occurrence of a promoter-like sequence upstream of kexF caused the overexpression of KexF. EnvR might 
repress the expression of kexEF to some extent. It was reported that EnvR controlled the expression of acrAB 
more than acrEF adjacent to the envR gene in E. coli31. However, the mRNA expression of acrA was constant 
even in Nov2-2 in Fig. 2, and the repression of acrAB by EnvR would be absent or less effective in K. pneumoniae.
The plasmid carrying kexEF genes conferred marked resistance to various antimicrobials, and no problem of 
compatibility between KexE and KexF was noted. However, KexF overexpression in Nov2-2 possibly functioned 
with AcrA as its periplasmic component.
In this study, the resistant mutants were highly isolated at 1–4 times the MIC of each antimicrobial chemical, 
and this corresponds well with the mutant selection window of antibiotics used clinically. Therefore, a multidrug-
resistant mutant may be generated by only a single administration of an antibiotic if a similar concentration is 
used.
Besides, chemicals such as pesticides are spread in fields, detergents are copiously used in daily life, and 
chemicals are disposed of down industrial drains in modern times. They are usually diluted to non-toxic con-
centrations for organisms before being released into the environment in Japan, but it is not considered whether 
the concentration is low enough to avoid selecting drug-resistant bacteria. Therefore, in terms of the problem of 
bacterial antimicrobial resistance, it may also be a considerable risk factor to release chemicals to environment 
even though they may be diluted to harmless levels for higher organism. Before chemicals are released into the 
environment, assessment of whether the concentration is low enough to avoid selecting resistant bacteria might 
be necessary in the future.
Materials and methods
Bacterial strains, plasmids, and media. The strains used in this study are listed in Table S5. The strain 
K. pneumoniae MGH78578 was a gift from Dr. Michael McClelland of the Sidney Kimmel Cancer Center in San 
Diego, CA, USA. The strain K. pneumoniae ATCC 10031 was purchased from the American Type Culture Col-
lection. This is an acrB-defective strain, which shows hyper-sensitivity to various  chemicals30. The strain E. coli 
KAM32 (ΔacrB, ΔydhE) and KAM33 (ΔacrAB, ΔydhE) are drug-hypersusceptible38. The strains K. pneumoniae 
and E. coli were grown aerobically in L medium (1% polypeptone, 0.5% yeast extract, and 0.5% NaCl, pH 7.0) 
at 37 °C. Mueller–Hinton broth was used when the minimum inhibitory concentration (MIC) was measured. 
Chloramphenicol (final concentration: 20 μg/ml) was added to L medium when needed. Cell growth was moni-
tored turbidimetrically at 650 nm. L-agar plates contained 1.5% agar.
PCR cloning of putative RND‑type efflux pump genes. The coding region of each RND-type efflux 
pump gene was amplified by PCR. The genome was isolated from K. pneumoniae MGH78578 and used as a 
template for PCR. The resultant plasmids are listed in Table S5. The primers used in this study are listed in 
Table S6. The conditions for PCR were 1 min at 94 °C, 1 min at 60 °C, and 5 min at 68 °C, repeated for 35 cycles. 
KOD-Plus DNA polymerase (TOYOBO Co. LTD., Osaka, Japan) was used for DNA amplification. After diges-
tion with appropriate restriction enzymes and gel purification, each DNA fragment was ligated to pSTV28, 
which was pre-digested with the appropriate enzyme. The absence of nucleotide substitution by PCR in ORFs 
was confirmed by sequencing.
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MIC determination. We previously described the method to measure minimum inhibitory concentrations 
(MICs) of various antimicrobial  agents7. The same experiment was repeated at least five times and the most 
reproducible values are shown in Tables.
Efflux assay for ethidium. The K. pneumoniae cells were grown in L medium until  OD650≈0.7. Cells were 
harvested and washed twice with modified Tanaka buffer (34 mM  KH2PO4, 64 mM  K2HPO4, 20 mM  (NH4)2SO4, 
0.3 mM  MgSO4, 1 μM  FeSO4, 1 μM  ZnCl2, 10 μM  CaCl2, and 2 mM  MgSO4, pH 7.0)39. Cells were resuspended 
in this buffer containing carbonyl cyanide m-chlorophenylhydrazone (CCCP, final concentration: 40 μM) and 
ethidium Br (final concentration: 10 μM). Cells were incubated at 37 °C for 0.5 h to deplete energy and eth-
idium was loaded into the cells during incubation. Energy-starved cells were harvested and washed twice with 
20  mM MOPS (3-morpholinopropanesulfonic acid)-TMAH (tetramethylammonium hydroxide) buffer (pH 
7.0) containing 2 mM  MgSO4 and 10 μM ethidium Br. The fluorescence intensity of ethidium was measured 
at an excitation wavelength of 500 nm and emission wavelength of 580 nm, respectively, using the fluorescence 
spectrophotometer F-2000 (Hitachi Co.). Lactate (final concentration: 20 mM) was added after measurement of 
the baseline for 1–2 min.
RNA preparation and reverse transcriptase‑polymerase chain reaction (RT‑PCR) analysis. The 
method of RNA preparation from K. pneumoniae was previously  described7. The extracted RNA was applied to 
RT-PCR with the QIAGEN One-Step RT-PCR Kit (QIAGEN K.K., Japan). The primers used for RT-PCR are 
listed in Table S6. PCR without a reverse-transcriptase reaction was performed to confirm the absence of detect-
able DNA contamination in the extracted RNA solution.
Western blotting. Everted membrane vesicles was prepared by the method described  previously30. Details 
of the method for Western blotting were also described  previously30. The anti-AcrB antibody to E. coli was used 
as a primary antibody, which also cross-reacted with AcrB from K. pneumoniae30. This antibody was provided 
by Dr. A. Yamaguchi (Institute of Scientific and Industrial Research, Osaka University). The secondary antibody, 
goat anti-rabbit IgG with horseradish peroxidase, was purchased from Thermo Fisher Scientific K.K.. The ECL 
Western blotting detection system (GE Healthcare UK Ltd., Buckinghamshire, England) was used for detection.
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